What Researchers Did
Researchers described their experience using hyperbaric oxygen therapy as an adjunctive treatment for 11 male patients with Fournier's syndrome, alongside antibiotics and sometimes surgery.
What They Found
The 11 male patients, with an average age of 59.5 years and often having diabetes, received antibiotic therapy and 5 to 24 cycles of hyperbaric oxygen therapy. The study reported excellent results with a 0% mortality rate and no complications, even for the 3 patients who underwent delayed reconstructive surgery.
What This Means for Canadian Patients
For Canadian patients suffering from severe infections like Fournier's syndrome, hyperbaric oxygen therapy, when used alongside standard treatments, may offer a beneficial adjunctive option. This approach could potentially lead to improved recovery, reduced mortality, and fewer complications, enhancing overall patient outcomes.
Canadian Relevance
This study has no direct Canadian connection as it was conducted by researchers outside of Canada.
Study Limitations
A significant limitation of this study is the small number of patients included, which restricts the generalizability of the findings.